The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium Enterobacter cloacae
Emma Forest Jordan Lehoux Alexandre Guy Thierry Durand Stéphane Audebert Luc Camoin Christopher DSpilling Céline Crauste Stéphane Canaan Jean Michel Brunel Jean‐Michel Bolla Jean‐François Cavalier
The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium Enterobacter cloacae
摘要
关键词
activity based‐protein profiling/antibiotic resistance/Cyclipostins and Cyclophostin analogs/drug enhancers/oxadiazolone derivatives分类
医药卫生引用本文复制引用
Emma Forest,Jordan Lehoux,Alexandre Guy,Thierry Durand,Stéphane Audebert,Luc Camoin,Christopher DSpilling,Céline Crauste,Stéphane Canaan,Jean Michel Brunel,Jean‐Michel Bolla,Jean‐François Cavalier..The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium Enterobacter cloacae[J].mLife,2025,4(3):P.259-274,16.基金项目
supported by the CNRS,INSERM,and Aix Marseille University.Proteomics analyses were carried out using the mass spectrometry facility of Marseille Proteomics(marseille‐proteomique.univ‐amu.fr)supported by IBISA （marseille‐proteomique.univ‐amu.fr）
the Cancéropôle PACA,the Provence‐Alpes‐Côte d''Azur Region,the Institut Paoli‐Calmettes,and Fonds Européen de Développement Regional(FEDER) （FEDER）
Emma Forest PhD fellowship is supported by the Ministère de l''Enseignement Supérieur et de la Recherche （）
The authors would like to thank Pierre Santucci(LISM UMR7255 CNRS)for his help with Biorender. （LISM UMR7255 CNRS）
